global pharmaceutical market. Tyagi told me: "European prices vary between 50 to 80 per cent
of US prices. The pricing policies in some European countries may be
hindering access to some drugs. People are paying higher prices, in the
sense that they are taking longer to get them".
Whatever the right and wrongs of the case, it does seem as if our European
neighbours are generally better able to get lower nationwide price agreements
on drug prices than our NHS. And this is going to have serious implications
when HIV treatment ceases to be 'ring-fenced' within the NHS and hospitals
are going to have to apportion funds for HIV drugs alongside those needed
for the treatment of other conditions - all from the same finite kitty.
Is HIV going to lose out?
page 5 of 5
contents
of issue 78
back
issues
the
gazette
recipes
small
ads
contacting
us
weblinks
All
prices below are from the European Aids Treatment Group - see www.eatg.org/drugprices
- except the UK price for Combivir, which is from the BNF - see: www.bnf.org
Prices for d4T are for 40mg capsules.
The UK is the second most expensive nation in Europe for HIV drugs on average. Prices in Euros per year. £1 = €1.60.
